first day of glp 1 90 Days on GLP-1 Therapy: What to Expect Guide Your First 90 Days On

Similar to patients with diabetes mellitus, those with obesity taking GLP-1 RAs have a significant reduction in MACE, all-cause death, myocardial infarction, and revascularisation, without significant differences in rates of cardiovascular death or stroke

It is therefore plausible that glucose-lowering by metformin may be more evident when glucose is administered orally

The randomized, double-blind, placebo-controlled trial by Depommier et al., 2019 demonstrates low risk of bias overall, with clearly defined eligibility criteria, intervention protocols, and prespecified outcomes

The tolerability gap may be less significant in practice than the raw nausea percentages suggest